Live Breaking News & Updates on Bristol Myers Squibb Celgene

Stay updated with breaking news from Bristol myers squibb celgene. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Two Choices for Resection Defect Repair Show Similar Success

Two novel devices are similarly effective for tissue approximation of large endoscopic resection defects, but each has advantages. ....

Houston , Texas , United-states , Baylor-college-of-medicine , Boston , Massachusetts , Eli-lilly , Salmaana-jawaid , Anita-afzali , Bristol-myers-squibb-celgene , University-of-cincinnati , Boston-scientific

IberVd Elicits Durable Responses in Transplant-Ineligible, Newly Diagnosed Multiple Myeloma

IberVd Elicits Durable Responses in Transplant-Ineligible, Newly Diagnosed Multiple Myeloma
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Dalhousie , New-brunswick , Canada , Canadian , Bristol-myers-squibb-celgene , Darrell-white , Lenalidomide-revlimid , International-myeloma-society , International-staging-system , Dalhousie-university , Amgen , Pfizer

Adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

Adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Brian-alexander , Eudocia-quant-lee , Isabel-arrillaga , Bristol-myers-squibb-celgene , Eli-lilly , Patrick-wen , Rifaquat-rahman , Keith-ligon , Puma-biotechnology-inc , Burroughs-wellcome-fund

Dana-Farber leads adaptive, efficient multi-a

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients. ....

Massachusetts , United-states , Dana-farber-cancer-institute , Boston , Isabel-arrillaga , Nicole-oliverio , Keith-ligon , Bristol-myers-squibb-celgene , Eudocia-quant-lee , Patrick-wen , Rifaquat-rahman , Brian-alexander

Dana-Farber Spearheads Streamlined Phase 2 Glioblastoma Trial

Dana-Farber Spearheads Streamlined Phase 2 Glioblastoma Trial
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Massachusetts , United-states , Dana-farber-cancer-institute , Eudocia-quant-lee , Patrick-wen , Bristol-myers-squibb-celgene , Keith-ligon , Brian-alexander , Eli-lilly , Rifaquat-rahman , Isabel-arrillaga , Division-of-neuropathology-at-brigham